⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX Lawsuit: Hagens Berman Scrutinizing MoonLake’s SLK Efficacy Claims After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority
globenewswire.com
MLTX
MLTX FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action – MLTX
globenewswire.com
MLTX
MLTX COURT ALERT: MoonLake Immunotherapeutics Investors are Notified the Compay has been Sued for Securities Fraud and are Notified to Contact BFA Law by December 15
newsfilecorp.com
MLTX
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX
prnewswire.com
MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MLTX
globenewswire.com
MLTX
Latest SueWallSt Podcast: What MLTX Investors Need to Know About the Lawsuit
accessnewswire.com
MLTX
MLTX CLASS ACTION: MoonLake Immunotherapeutics Sued for Securities Fraud after 90% Stock Drop - Contact BFA Law if You Suffered Losses
accessnewswire.com
MLTX
MLTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
MLTX